TheraRadar
← Back
Data updated: Mar 29, 2026

AREVA PHARMS

Infectious DiseaseRespiratory
Generics

AREVA PHARMS is a generic drug manufacturer focused on Infectious Disease, Respiratory.

2008
Since
5
Drugs
-
Trials
20
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

FUROSEMIDE 2026-01-08
FUROSEMIDE 2025-09-12
Labeling
FUROSEMIDE 2025-09-08
Labeling
FUROSEMIDE 2025-08-06
Labeling
CASPOFUNGIN ACETATE 2025-07-18
FUROSEMIDE 2025-07-17
FLUDARABINE PHOSPHATE 2025-07-01
Labeling
PAMIDRONATE DISODIUM 2025-05-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Respiratory 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GSK big-pharma
Infectious Disease, Respiratory
Sanofi big-pharma
Infectious Disease, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Respiratory
APOTHECON specialty
Infectious Disease, Respiratory
PHARMACIA AND UPJOHN big-pharma
Infectious Disease, Respiratory